None
| Website | http://www.zymogenetics.com |
| Ticker | NASDAQ:ZGEN |
| Revenue | $43 million |
| Employees | 179 (79 on RocketReach) |
| Founded | 1981 |
| Address | 1201 Eastlake Ave E, Seattle, Washington 98102, US |
| Phone | +1 301-816-2424 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+77 more
(view full list)
|
| Industry | Biotechnology, Therapeutics, Health Care |
| Web Rank | 76653 |
| Web Visits | 541000 |
| Keywords | Biotechnology, Recombinant Proteins, Pharmaceutical Research, Bioprocessing, Protein Engineering, Cell Culture, Therapeutic Proteins, Molecular Biology, Biopharmaceutical Development, Drug Delivery, Drug Discovery, Clinical Trials, Biologics Manufacturing, Biotechnology Research, Gene Therapy, Pharmaceutical Research And Development, Pharmaceutical Manufacturing, Immunology, Oncology, Genetic Engineering |
| Competitors | Roche, Merck & Co., Inc., Genentech, Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Biogen, Receptos, a wholly-owned subsidiary of Celgene, Lilly India +45 more (view full list) |
Looking for a particular ZymoGenetics employee's phone or email?
The ZymoGenetics annual revenue was $43 million in 2026.
Kevin Cook is the CMO of ZymoGenetics.
79 people are employed at ZymoGenetics.
ZymoGenetics is based in Seattle, Washington.